A weekly trade journal catering to the Indian chemical industry
backBack

calendar 24 January, 2025 16:35:55 IST

CSIR opens new innovation complex in Mumbai

Article image

The Council of Scientific and Industrial Research (CSIR) formally inaugurated an ‘Innovation Complex’ in Mumbai on January 17. The complex, in the works for over a decade, spans nine floors and features 24 ready-to-move incubation labs with high-end scientific infrastructure, furnished office spaces, and networking zones designed to cater to start-ups, MSMEs, industry stakeholders, and CSIR labs. 

The complex is designed to function as the corporate centre of CSIR in the financial capital of the country, and will serve as a hub for business development, regulatory compliance, and innovation support for stakeholders in sectors like healthcare & pharmaceuticals, chemicals, materials, and energy. The complex seeks to bridge the gap between lab-scale research and industry implementation by fostering collaboration between start-ups, MSMEs, and CSIR’s network of researchers and innovators. 

Speaking after virtually inaugurating the facility, the Union Minister of State for Science and Technology, Dr. Jitendra Singh, said that the complex will be used to strengthen the business development and tech-transfer activities of CSIR labs, leveraging the unique opportunities offered by Mumbai which will serve as a hub for other incubators operating within the CSIR labs.

He said the facility will aid in faster technology transfers and address needs from lab-to-regulator and regulator-to-industry domains.  

The inauguration event witnessed the participation of industry leaders, foreign delegates from Norway, Switzerland, and Germany, and over 1,000 scientists from CSIR labs across India.

Speaking at the event, CSIR’s Director General Dr. N. Kalaiselvi stated that every year around 10 to 15 technologies are developed by CSIR, which are globally appreciated. She highlighted some of the outstanding achievements of CSIR labs including steel slag technology for use on national highways, commercial production of hydrazine hydrate, indigenous development of paracetamol process, zero liquid discharge plants, etc. In addition to partnerships within the country, CSIR is collaborating with nations like Germany, Norway, Switzerland, etc, she informed.

Referring to the innovation complex, Dr. Kalaiselvi called it the “shaping of a decadal dream into reality” and hoped that it would bring R&D infrastructure, industries and innovators on a single platform where they would discuss ideas, conceptualise innovations and bring them into the market for wider use.

“The establishment of Innovation Complex, Mumbai is very well aligned with the Government of India’s vision of ‘Viksit Bharat 2047’ in the area of science and technology by bridging the gap between technology, industry and society” said Dr. Kalaiselvi.

Dr. V.K. Paul, member, Niti Aayog, recalled the efforts of CSIR during the Covid pandemic. He appreciated CSIR for developing CRISPR-diagnostic tests and deployment of cost-effective oxygen concentrators to remote corners of the country.

Dr. V.K. Saraswat, member, Niti Aayog, advised to take innovation to industry rather than calling industry to innovation.

Dr. Ram Vishwakarma, the driving force behind setting up the complex, described the facility as a critical enabler for startups, MSMEs, and academic collaborations. “The complex will not do any research of its own. It will build and support translational enabling protocols and platforms for disruptive innovation. It will incubate and support startups, MSMEs and industries, besides partnering with manufacturing clusters around Maharashtra & Gujarat, industry associations, incubators, research institution and local governments,” he informed.

The event also witnessed 50 technology transfers from CSIR institutes to startups, MSMEs and institutions. The Innovation Complex also signed MoUs with various institutions to boost innovation and entrepreneurship. These included partnerships with IIT-Bombay’s SINE, iCreate, National Research Development Corporation (NRDC), BCIL, and Indian Pharma Alliance (IPA) to support start up incubation, mentorship, technology development across various sectors, fostering joint R&D and capacity building.

Dr. Vishwakarma also informed that eight CSIR labs - CSMCRI-Bhavnagar, IIMT-Bhubaneshwar, NIIST-Thiruvananthapuram, CEERI-Pilani, CGCRI-Kolkata, IICT-Hyderabad, NIO-Goa and AMPRI-Bhopal – and their industry partners have already signed up to take space in the innovation complex.

CSIR has a network of 37 national laboratories, 39 outreach centres, and three units with a pan-India presence. It covers a wide spectrum of science and technology ranging oceanography, geophysics, chemicals, drugs, genomics, biotechnology and nanotechnology to mining, aeronautics, instrumentation, environmental engineering and information technology.

article image
calender image

calender image 9 November, 2026 20:19:59 IST

Will India’s butadiene paradox resolve through integrated C4 value chain development?

India is at an important turning point in the development of its butadiene value chain. For years, the country...
article image

calender image 9 November, 2026 19:59:03 IST

GAIL subsidiary commissions PTA plant at Mangalore

GAIL (India) Ltd. has commissioned a 1.25-mtpa purified terephthalic acid (PTA) plant at the Mangalore Special Economic Zone...

PRINT EDITION

View Past Issues

Search For

Exhibitions & Conferences

ChemExpo IndiaChemProTechChemLogistics India

Watch

KKBangEchemiAPi ChinaGPCA ForumCPHI PMEC INDIA